BioSpace News Archive

Pharm Country

Frontage Expands Bioanalytical Capacity and Capabilities to Support Biologic Drug Development, Biomarkers and Cell and Gene Therapy

Frontage Laboratories, Inc., a contract research organization providing integrated, science-driven, product development services, is pleased to announce the expansion of their bioanalytical laboratories.

October 3, 2019
·
2 min read
Business

BioIVT Appoints Global Business Strategist Lori Ball as Its Chief Operating Officer

Ms. Ball has held senior global leadership roles in the life sciences industry for more than 18 years

October 3, 2019
·
3 min read
Genetown

Summit Therapeutics Reports Ridinilazole Significantly Improved Short and Longer-Term Quality of Life Measures in Patients with C. difficile Infection Compared to Standard of Care

Summit Therapeutics plc announced that it presented results from the Phase 2 clinical trial of ridinilazole in C. difficile infection (‘CDI’) detailing improvements in patient quality of life following antibiotic treatment for CDI.

October 3, 2019
·
8 min read
FDA

Immunexpress Announces Closing of Private Funding Round

Funding will support the development of SeptiCyte™ RAPID through FDA 510(k) Clearance

October 3, 2019
·
3 min read
Pharm Country

GRYT Health Acquires Vivibot Chatbot and Debuts New Desktop Messaging Feature to Make Connections and Conversations Around Cancer Easier

Integration of Science-Based Health Bot, “Vivibot,” Helps Improve the Mental Well-Being of Users

October 3, 2019
·
4 min read
Pharm Country

Neuronetics® Unveils Promising New Depression Research Data at Psych Congress

New findings confirm safety and efficacy of NeuroStar® Advanced Therapy, a non-drug depression treatment, setting the stage for future indications

October 3, 2019
·
9 min read
Drug Development

Zydus Announces Positive Results From EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NAFLD and NASH

Statistically significant 44.39 % reduction in ALT (alanine aminotransferase) observed with Saroglitazar Magnesium treated patients

October 3, 2019
·
3 min read
Business

Akero Therapeutics and InSphero partner to evaluate AKR-001 using InSphero’s 3D InSight™ Human Liver Disease platform

3D InSight™ Human Liver Disease Platform will be used to screen effects of Akero lead program AKR-001 on underlying metabolic and fibrotic drivers of NAFLD and NASH.

October 3, 2019
·
5 min read
BioMidwest

Bright Health Announces 2020 Plan Details and Pricing for New York City

Bright Health will continue offering plans in the boroughs of Brooklyn, Queens and Manhattan.

October 3, 2019
·
6 min read
Policy

Biocept Announces Issuance of South Korean Patent Covering its Target Selector™ Oncogene Mutation Enrichment and Detection Platform

Expands intellectual property to 37 issued patents globally for highly sensitive methods of detecting cancer biomarkers

October 3, 2019
·
5 min read